Longitudinal Study on the Evolution Trend and Influencing Factors of Postoperative Reflux of Esophageal Cancer Based on PEPTEST Technique
China Cancer Foundation Beijing Hope Marathon Fund
1 other identifier
observational
138
1 country
1
Brief Summary
The goal of this observational study intends to explore the evolution trend and related factors of postoperative reflux of esophageal cancer based on PEPTEST detection, in order to identify postoperative reflux The main question it aims to answer are: to provide evidence for high-risk groups, improvement of surgical methods for esophageal cancer, and development of health education programs to prevent postoperative reflux. Using convenient sampling method, patients undergoing esophagectomy in thoracic surgery Department of Cancer Hospital of Chinese Academy of Medical Sciences from January 1, 2023 were continuously enrolled. PEPTEST was performed once before surgery, before discharge, 1 month, 3 months, and 6 months after surgery. The incidence of pathological reflux at 5 time points before and after surgery was observed and compared (that is, both T-line and C-line were shown). The trend of pepsin content in saliva before and after operation; The relationship between pathological reflux and surgical factors; The relationship between pathological reflux and life habits after operation; Relationship between pathological regurgitation and demographic characteristics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2023
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedFirst Posted
Study publicly available on registry
July 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedJuly 19, 2024
March 1, 2024
9 months
August 26, 2023
July 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of pathological regurgitation
Incidence of pathological regurgitation at 5 time points before and after surgery.
2023.1.1-2023.12.1
Study Arms (5)
Before surgery
A patient with esophageal cancer before surgery
Before discharge
Patients with esophageal cancer who were not discharged after surgery
1 month after surgery
One month after surgery for esophageal cancer
3 months after surgery
Three months after surgery for esophageal cancer
6 months after surgery
Six months after surgery for esophageal cancer
Interventions
Quantitative determination of gastric salivary amylase。
Eligibility Criteria
Patients who underwent resection for esophageal cancer were continuously enrolled.
You may qualify if:
- Patients who were pathologically diagnosed with esophageal cancer and underwent esophagectomy for esophageal cancer.
- The patient can communicate in Mandarin.
- Those who can come to the hospital for review on time.
You may not qualify if:
- People with cognitive impairment or mental illness.
- Complicating other serious life-threatening diseases (such as leukemia or autoimmune diseases).
- Unwilling to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2023
First Posted
July 19, 2024
Study Start
March 1, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
July 19, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share